A nested case-control study for joint construction of Alzheimer's disease risk prediction model based on molecular markers

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023777

Enrollment

Unknown

Registered

2019-06-11

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Healthy group:Nil

mild cognitive impairment ( MCI) group:Nil

Alzheimer disease group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Residents aged 65 years or more who living in beishan, hemu and xixi communities of hangzhou, with normal cognitive function and able to cooperate with the investigation and relevant referrals were selected.

Exclusion criteria

Exclusion criteria: Brain tumors, Parkinson's disease, depression and other neurological disorders; Exclusion of hypothyroidism; Eliminate vitamin B12 deficiency; Participants were not given anticonvulsants, neuroleptics, antiemetic agents (e.g., antiepileptics), antipsychotics, etc. No serious blood diseases, including chronic abnormalities of whole blood cells and anemia requiring treatment/transfusion; There is no acute critical illness (such as acute myocardial infarction, cerebral infarction, severe heart, lung, liver, kidney disease).

Design outcomes

Primary

Measure	Time frame
Gene sequence;	—

Countries

China

Contacts

Public ContactLi Yang

Zhejiang Hospital

phoebe84331@hotmail.com+86 18268823078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026